ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Spontaneous Urticaria Drug Treatment Market Research Report 2026
Published Date: 2026-04-15
|
Report Code: QYRE-Auto-20E17382
Home | Market Reports
Global Chronic Spontaneous Urticaria Drug Treatment Market Research Report 2024
BUY CHAPTERS

Global Chronic Spontaneous Urticaria Drug Treatment Market Research Report 2026

Code: QYRE-Auto-20E17382
Report
2026-04-15
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan N.V.
Sanofi
GlaxoSmithKline PLC
Bayer
Merck
Aurobindo Pharma
Hikma Pharmaceuticals
WOCKHARDT
AbbVie
Cipla Ltd
F Hoffmann La Roche Ltd
Teva Pharmaceutical Industries Ltd
Pfizer Inc
Novartis
Eli Lilly and Company
Allergan plc
Lupin Ltd

Chronic Spontaneous Urticaria Drug Treatment Market

The global Chronic Spontaneous Urticaria Drug Treatment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, is defined as the presence of urticaria most of the time during a week and this condition lasts for 6 weeks or more. About 40% of patients are accompanied by angioedema. The standard treatment for CSU is mainly second-generation H1 antihistamines, often at higher than conventional doses, combined with H2 antihistamines and leukotriene modulators.
CSU is a chronic inflammatory skin disease characterized by the sudden onset of hives and/or deep swelling of the skin. Despite standard of care treatments, patients with CSU often experience symptoms such as persistent itching or burning sensations that can be debilitating and significantly impact quality of life. Swelling usually occurs on the face, hands, and feet and can also affect the throat and upper respiratory tract. CSU is commonly treated with antihistamines, but in patients with limited available treatment options, the condition remains uncontrolled in up to 50% of patients.
This report delivers a comprehensive overview of the global Chronic Spontaneous Urticaria Drug Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Spontaneous Urticaria Drug Treatment. The Chronic Spontaneous Urticaria Drug Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chronic Spontaneous Urticaria Drug Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chronic Spontaneous Urticaria Drug Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Chronic Spontaneous Urticaria Drug Treatment Market Report

Report Metric Details
Report Name Chronic Spontaneous Urticaria Drug Treatment Market
Segment by Type
  • Antihistamine
  • Dupixent
  • Other
Segment by Application
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mylan N. V., Sanofi, GlaxoSmithKline, Bayer, Merck, Aurobindo Pharma, Hikma Pharmaceuticals, WOCKHARDT, AbbVie, Inc., Cipla Inc., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries, Ltd., Pfizer, Inc., Novartis AG, Eli Lilly and Company, Allergan, Lupin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Chronic Spontaneous Urticaria Drug Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Spontaneous Urticaria Drug Treatment Market report?

Ans: The main players in the Chronic Spontaneous Urticaria Drug Treatment Market are Mylan N. V., Sanofi, GlaxoSmithKline, Bayer, Merck, Aurobindo Pharma, Hikma Pharmaceuticals, WOCKHARDT, AbbVie, Inc., Cipla Inc., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries, Ltd., Pfizer, Inc., Novartis AG, Eli Lilly and Company, Allergan, Lupin

What are the Application segmentation covered in the Chronic Spontaneous Urticaria Drug Treatment Market report?

Ans: The Applications covered in the Chronic Spontaneous Urticaria Drug Treatment Market report are Children, Adult

What are the Type segmentation covered in the Chronic Spontaneous Urticaria Drug Treatment Market report?

Ans: The Types covered in the Chronic Spontaneous Urticaria Drug Treatment Market report are Antihistamine, Dupixent, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antihistamine
1.2.3 Dupixent
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chronic Spontaneous Urticaria Drug Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Spontaneous Urticaria Drug Treatment Market Perspective (2021–2032)
2.2 Global Chronic Spontaneous Urticaria Drug Treatment Growth Trends by Region
2.2.1 Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Chronic Spontaneous Urticaria Drug Treatment Historic Market Size by Region (2021–2026)
2.2.3 Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Region (2027–2032)
2.3 Chronic Spontaneous Urticaria Drug Treatment Market Dynamics
2.3.1 Chronic Spontaneous Urticaria Drug Treatment Industry Trends
2.3.2 Chronic Spontaneous Urticaria Drug Treatment Market Drivers
2.3.3 Chronic Spontaneous Urticaria Drug Treatment Market Challenges
2.3.4 Chronic Spontaneous Urticaria Drug Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Spontaneous Urticaria Drug Treatment Players by Revenue
3.1.1 Global Top Chronic Spontaneous Urticaria Drug Treatment Players by Revenue (2021–2026)
3.1.2 Global Chronic Spontaneous Urticaria Drug Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Chronic Spontaneous Urticaria Drug Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Chronic Spontaneous Urticaria Drug Treatment Revenue
3.4 Global Chronic Spontaneous Urticaria Drug Treatment Market Concentration Ratio
3.4.1 Global Chronic Spontaneous Urticaria Drug Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Spontaneous Urticaria Drug Treatment Revenue in 2025
3.5 Global Key Players of Chronic Spontaneous Urticaria Drug Treatment Head Offices and Areas Served
3.6 Global Key Players of Chronic Spontaneous Urticaria Drug Treatment, Products and Applications
3.7 Global Key Players of Chronic Spontaneous Urticaria Drug Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Chronic Spontaneous Urticaria Drug Treatment Breakdown Data by Type
4.1 Global Chronic Spontaneous Urticaria Drug Treatment Historic Market Size by Type (2021–2026)
4.2 Global Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Type (2027–2032)
5 Chronic Spontaneous Urticaria Drug Treatment Breakdown Data by Application
5.1 Global Chronic Spontaneous Urticaria Drug Treatment Historic Market Size by Application (2021–2026)
5.2 Global Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Chronic Spontaneous Urticaria Drug Treatment Market Size (2021–2032)
6.2 North America Chronic Spontaneous Urticaria Drug Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2021–2026)
6.4 North America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Spontaneous Urticaria Drug Treatment Market Size (2021–2032)
7.2 Europe Chronic Spontaneous Urticaria Drug Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2021–2026)
7.4 Europe Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size (2021–2032)
8.2 Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size (2021–2032)
9.2 Latin America Chronic Spontaneous Urticaria Drug Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2021–2026)
9.4 Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size (2021–2032)
10.2 Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mylan N. V.
11.1.1 Mylan N. V. Company Details
11.1.2 Mylan N. V. Business Overview
11.1.3 Mylan N. V. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.1.4 Mylan N. V. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.1.5 Mylan N. V. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Chronic Spontaneous Urticaria Drug Treatment Introduction
11.2.4 Sanofi Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.2.5 Sanofi Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Chronic Spontaneous Urticaria Drug Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Chronic Spontaneous Urticaria Drug Treatment Introduction
11.4.4 Bayer Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.4.5 Bayer Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Chronic Spontaneous Urticaria Drug Treatment Introduction
11.5.4 Merck Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.5.5 Merck Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Details
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Chronic Spontaneous Urticaria Drug Treatment Introduction
11.6.4 Aurobindo Pharma Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.6.5 Aurobindo Pharma Recent Development
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Details
11.7.2 Hikma Pharmaceuticals Business Overview
11.7.3 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Drug Treatment Introduction
11.7.4 Hikma Pharmaceuticals Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.7.5 Hikma Pharmaceuticals Recent Development
11.8 WOCKHARDT
11.8.1 WOCKHARDT Company Details
11.8.2 WOCKHARDT Business Overview
11.8.3 WOCKHARDT Chronic Spontaneous Urticaria Drug Treatment Introduction
11.8.4 WOCKHARDT Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.8.5 WOCKHARDT Recent Development
11.9 AbbVie, Inc.
11.9.1 AbbVie, Inc. Company Details
11.9.2 AbbVie, Inc. Business Overview
11.9.3 AbbVie, Inc. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.9.4 AbbVie, Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.9.5 AbbVie, Inc. Recent Development
11.10 Cipla Inc.
11.10.1 Cipla Inc. Company Details
11.10.2 Cipla Inc. Business Overview
11.10.3 Cipla Inc. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.10.4 Cipla Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.10.5 Cipla Inc. Recent Development
11.11 F. Hoffmann La Roche Ltd.
11.11.1 F. Hoffmann La Roche Ltd. Company Details
11.11.2 F. Hoffmann La Roche Ltd. Business Overview
11.11.3 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.11.4 F. Hoffmann La Roche Ltd. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.11.5 F. Hoffmann La Roche Ltd. Recent Development
11.12 Teva Pharmaceutical Industries, Ltd.
11.12.1 Teva Pharmaceutical Industries, Ltd. Company Details
11.12.2 Teva Pharmaceutical Industries, Ltd. Business Overview
11.12.3 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.12.4 Teva Pharmaceutical Industries, Ltd. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.12.5 Teva Pharmaceutical Industries, Ltd. Recent Development
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Chronic Spontaneous Urticaria Drug Treatment Introduction
11.13.4 Pfizer, Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.13.5 Pfizer, Inc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Chronic Spontaneous Urticaria Drug Treatment Introduction
11.14.4 Novartis AG Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.14.5 Novartis AG Recent Development
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Details
11.15.2 Eli Lilly and Company Business Overview
11.15.3 Eli Lilly and Company Chronic Spontaneous Urticaria Drug Treatment Introduction
11.15.4 Eli Lilly and Company Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.15.5 Eli Lilly and Company Recent Development
11.16 Allergan
11.16.1 Allergan Company Details
11.16.2 Allergan Business Overview
11.16.3 Allergan Chronic Spontaneous Urticaria Drug Treatment Introduction
11.16.4 Allergan Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.16.5 Allergan Recent Development
11.17 Lupin
11.17.1 Lupin Company Details
11.17.2 Lupin Business Overview
11.17.3 Lupin Chronic Spontaneous Urticaria Drug Treatment Introduction
11.17.4 Lupin Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
11.17.5 Lupin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Mylan N.V.
Sanofi
GlaxoSmithKline PLC
Bayer
Merck
Aurobindo Pharma
Hikma Pharmaceuticals
WOCKHARDT
AbbVie
Cipla Ltd
F Hoffmann La Roche Ltd
Teva Pharmaceutical Industries Ltd
Pfizer Inc
Novartis
Eli Lilly and Company
Allergan plc
Lupin Ltd
List of Tables
 Table 1. Global Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Antihistamine
 Table 3. Key Players of Dupixent
 Table 4. Key Players of Other
 Table 5. Global Chronic Spontaneous Urticaria Drug Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Region (2021–2026)
 Table 9. Global Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Region (2027–2032)
 Table 11. Chronic Spontaneous Urticaria Drug Treatment Market Trends
 Table 12. Chronic Spontaneous Urticaria Drug Treatment Market Drivers
 Table 13. Chronic Spontaneous Urticaria Drug Treatment Market Challenges
 Table 14. Chronic Spontaneous Urticaria Drug Treatment Market Restraints
 Table 15. Global Chronic Spontaneous Urticaria Drug Treatment Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Players (2021–2026)
 Table 17. Global Top Chronic Spontaneous Urticaria Drug Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Chronic Spontaneous Urticaria Drug Treatment Revenue, 2025
 Table 18. Ranking of Global Top Chronic Spontaneous Urticaria Drug Treatment Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Chronic Spontaneous Urticaria Drug Treatment Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Chronic Spontaneous Urticaria Drug Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Chronic Spontaneous Urticaria Drug Treatment, Products and Applications
 Table 22. Global Key Players of Chronic Spontaneous Urticaria Drug Treatment, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Chronic Spontaneous Urticaria Drug Treatment Revenue Market Share by Type (2021–2026)
 Table 26. Global Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Chronic Spontaneous Urticaria Drug Treatment Revenue Market Share by Type (2027–2032)
 Table 28. Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Chronic Spontaneous Urticaria Drug Treatment Revenue Market Share by Application (2021–2026)
 Table 30. Global Chronic Spontaneous Urticaria Drug Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Chronic Spontaneous Urticaria Drug Treatment Revenue Market Share by Application (2027–2032)
 Table 32. North America Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size by Country (US$ Million), 2027–2032
 Table 47. Mylan N. V. Company Details
 Table 48. Mylan N. V. Business Overview
 Table 49. Mylan N. V. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 50. Mylan N. V. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 51. Mylan N. V. Recent Development
 Table 52. Sanofi Company Details
 Table 53. Sanofi Business Overview
 Table 54. Sanofi Chronic Spontaneous Urticaria Drug Treatment Product
 Table 55. Sanofi Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 56. Sanofi Recent Development
 Table 57. GlaxoSmithKline Company Details
 Table 58. GlaxoSmithKline Business Overview
 Table 59. GlaxoSmithKline Chronic Spontaneous Urticaria Drug Treatment Product
 Table 60. GlaxoSmithKline Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 61. GlaxoSmithKline Recent Development
 Table 62. Bayer Company Details
 Table 63. Bayer Business Overview
 Table 64. Bayer Chronic Spontaneous Urticaria Drug Treatment Product
 Table 65. Bayer Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 66. Bayer Recent Development
 Table 67. Merck Company Details
 Table 68. Merck Business Overview
 Table 69. Merck Chronic Spontaneous Urticaria Drug Treatment Product
 Table 70. Merck Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 71. Merck Recent Development
 Table 72. Aurobindo Pharma Company Details
 Table 73. Aurobindo Pharma Business Overview
 Table 74. Aurobindo Pharma Chronic Spontaneous Urticaria Drug Treatment Product
 Table 75. Aurobindo Pharma Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 76. Aurobindo Pharma Recent Development
 Table 77. Hikma Pharmaceuticals Company Details
 Table 78. Hikma Pharmaceuticals Business Overview
 Table 79. Hikma Pharmaceuticals Chronic Spontaneous Urticaria Drug Treatment Product
 Table 80. Hikma Pharmaceuticals Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 81. Hikma Pharmaceuticals Recent Development
 Table 82. WOCKHARDT Company Details
 Table 83. WOCKHARDT Business Overview
 Table 84. WOCKHARDT Chronic Spontaneous Urticaria Drug Treatment Product
 Table 85. WOCKHARDT Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 86. WOCKHARDT Recent Development
 Table 87. AbbVie, Inc. Company Details
 Table 88. AbbVie, Inc. Business Overview
 Table 89. AbbVie, Inc. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 90. AbbVie, Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 91. AbbVie, Inc. Recent Development
 Table 92. Cipla Inc. Company Details
 Table 93. Cipla Inc. Business Overview
 Table 94. Cipla Inc. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 95. Cipla Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 96. Cipla Inc. Recent Development
 Table 97. F. Hoffmann La Roche Ltd. Company Details
 Table 98. F. Hoffmann La Roche Ltd. Business Overview
 Table 99. F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 100. F. Hoffmann La Roche Ltd. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 101. F. Hoffmann La Roche Ltd. Recent Development
 Table 102. Teva Pharmaceutical Industries, Ltd. Company Details
 Table 103. Teva Pharmaceutical Industries, Ltd. Business Overview
 Table 104. Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 105. Teva Pharmaceutical Industries, Ltd. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 106. Teva Pharmaceutical Industries, Ltd. Recent Development
 Table 107. Pfizer, Inc. Company Details
 Table 108. Pfizer, Inc. Business Overview
 Table 109. Pfizer, Inc. Chronic Spontaneous Urticaria Drug Treatment Product
 Table 110. Pfizer, Inc. Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 111. Pfizer, Inc. Recent Development
 Table 112. Novartis AG Company Details
 Table 113. Novartis AG Business Overview
 Table 114. Novartis AG Chronic Spontaneous Urticaria Drug Treatment Product
 Table 115. Novartis AG Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 116. Novartis AG Recent Development
 Table 117. Eli Lilly and Company Company Details
 Table 118. Eli Lilly and Company Business Overview
 Table 119. Eli Lilly and Company Chronic Spontaneous Urticaria Drug Treatment Product
 Table 120. Eli Lilly and Company Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 121. Eli Lilly and Company Recent Development
 Table 122. Allergan Company Details
 Table 123. Allergan Business Overview
 Table 124. Allergan Chronic Spontaneous Urticaria Drug Treatment Product
 Table 125. Allergan Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 126. Allergan Recent Development
 Table 127. Lupin Company Details
 Table 128. Lupin Business Overview
 Table 129. Lupin Chronic Spontaneous Urticaria Drug Treatment Product
 Table 130. Lupin Revenue in Chronic Spontaneous Urticaria Drug Treatment Business (US$ Million), 2021–2026
 Table 131. Lupin Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Chronic Spontaneous Urticaria Drug Treatment Picture
 Figure 2. Global Chronic Spontaneous Urticaria Drug Treatment Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Type: 2025 vs 2032
 Figure 4. Antihistamine Features
 Figure 5. Dupixent Features
 Figure 6. Other Features
 Figure 7. Global Chronic Spontaneous Urticaria Drug Treatment Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Application: 2025 vs 2032
 Figure 9. Children Case Studies
 Figure 10. Adult Case Studies
 Figure 11. Chronic Spontaneous Urticaria Drug Treatment Report Years Considered
 Figure 12. Global Chronic Spontaneous Urticaria Drug Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Chronic Spontaneous Urticaria Drug Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Region: 2025 vs 2032
 Figure 15. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Players in 2025
 Figure 16. Global Chronic Spontaneous Urticaria Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Chronic Spontaneous Urticaria Drug Treatment Revenue in 2025
 Figure 18. North America Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Chronic Spontaneous Urticaria Drug Treatment Market Share by Country (2021–2032)
 Figure 20. United States Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Chronic Spontaneous Urticaria Drug Treatment Market Share by Country (2021–2032)
 Figure 24. Germany Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Chronic Spontaneous Urticaria Drug Treatment Market Share by Region (2021–2032)
 Figure 32. China Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Chronic Spontaneous Urticaria Drug Treatment Market Share by Country (2021–2032)
 Figure 40. Mexico Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Chronic Spontaneous Urticaria Drug Treatment Market Share by Country (2021–2032)
 Figure 44. Israel Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Chronic Spontaneous Urticaria Drug Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Mylan N. V. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 48. Sanofi Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 49. GlaxoSmithKline Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 50. Bayer Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 51. Merck Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 52. Aurobindo Pharma Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 53. Hikma Pharmaceuticals Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 54. WOCKHARDT Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 55. AbbVie, Inc. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 56. Cipla Inc. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 57. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 58. Teva Pharmaceutical Industries, Ltd. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 59. Pfizer, Inc. Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 60. Novartis AG Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 61. Eli Lilly and Company Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 62. Allergan Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 63. Lupin Revenue Growth Rate in Chronic Spontaneous Urticaria Drug Treatment Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Chronic Urticaria Medicine Market Research Report 2024
Global Chronic Idiopathic Urticaria Treatment Market Research Report 2024
Chronic Spontaneous Urticaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Urticaria Or Hives Drug Market Research Report 2025
Urticaria Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cutaneous Mastocytosis Treatment Market Insights Forecast to 2030
Global Papular Urticaria Drug Market Research Report 2024
Cetirizine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma and Cetirizine OTC Market Research Report 2024
Global Allergy Treatment Loratadine Market Research Report 2024
Global Allergic Rhinitis Immunotherapies Market Research Report 2024
Kounis Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihistamine Loratadine Market Research Report 2024
Global Drugs to Treat Allergic Diseases Market Research Report 2024
Global Loratadine Market Insights Forecast to 2030
Global Allergy Treatment Drugs Market Research Report 2025
Global Type 2 Inflammation Targeting Drugs Market Research Report 2024
Seasonal Allergy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Allergic Conjunctivitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergy Diagnostics Reagent and Kit Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions